Lifileucel (Amtagvi): A cellular therapy for melanoma.
Med Lett Drugs Ther
; 66(1701): e77-e78, 2024 Apr 29.
Article
in En
| MEDLINE
| ID: mdl-38691651
Key words
Amtagvi; Braftovi; Cotellic; Keytruda; Mekinist; Mektovi; Opdivo; Opdualag; Tafinlar; Yervoy; Zelboraf; adverse effects; aldesleukin; binimetinib; cobimetinib; cyclophosphamide; dabrafenib; dosage; drug interactions; efficacy; encorafenib; fludarabine; ipilimumab; lifileucel; melanoma; nivolumab; pembrolizumab; relatlimib; safety; trametinib; vemurafenib
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphocytes, Tumor-Infiltrating
/
Melanoma
Limits:
Humans
Language:
En
Journal:
Med Lett Drugs Ther
Year:
2024
Document type:
Article